Literature DB >> 24767619

Prospective associations between the cortisol awakening response and first onsets of anxiety disorders over a six-year follow-up--2013 Curt Richter Award Winner.

Emma K Adam1, Suzanne Vrshek-Schallhorn2, Ashley D Kendall2, Susan Mineka2, Richard E Zinbarg3, Michelle G Craske4.   

Abstract

Cross-sectional associations have been found between anxiety disorders (ADs) and hypothalamic-pituitary-adrenal (HPA) axis functioning, as measured by levels of salivary cortisol, but prospective data are lacking, as are studies examining specific ADs. We have previously shown that one aspect of the diurnal rhythm of cortisol, the cortisol awakening response (CAR), prospectively predicts both new onsets and recurrences of major depressive disorder (MDD). Here we sought to examine whether it also predicts ADs. Participants (N=232) were drawn from the larger Northwestern-UCLA Youth Emotion Project, a two-site, longitudinal study of older adolescents, which aims to identify common and specific risk factors for mood and anxiety disorders. After baseline interviews for mental health diagnoses, a subset of adolescents completed a three-day cortisol sampling protocol measuring the CAR and other diurnal rhythm indices. Participants with past or current anxiety disorders at the time of cortisol measurement were excluded and Cox regression (survival analysis) was used to predict first onsets of ADs over the subsequent six years. AD onsets (N=25), the largest subset of which were social anxiety disorder (SAD) onsets (N=11), were observed over six annual follow up diagnostic interviews. Even when statistically adjusting for past and prospective MDD onsets and other covariates, a higher CAR significantly predicted increased first onsets of ADs (HR=2.20, p<.05). A higher CAR was also a strong and significant predictor of the subset of SAD onsets (HR=5.37, p<.005). Implications for the etiology of ADs, with a focus on SAD, are discussed.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Adolescence; Anxiety disorders; Cortisol; Cortisol awakening response; Diurnal rhythms; Hypothalamic pituitary adrenal axis; Non-proportional hazard models; Prospective; Social anxiety disorder; Social phobia

Mesh:

Substances:

Year:  2014        PMID: 24767619      PMCID: PMC4108290          DOI: 10.1016/j.psyneuen.2014.02.014

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN: 0306-4530            Impact factor:   4.905


  67 in total

Review 1.  Assessing salivary cortisol in large-scale, epidemiological research.

Authors:  Emma K Adam; Meena Kumari
Journal:  Psychoneuroendocrinology       Date:  2009-07-31       Impact factor: 4.905

2.  Severity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication Adolescent Supplement.

Authors:  Ronald C Kessler; Shelli Avenevoli; Jane Costello; Jennifer Greif Green; Michael J Gruber; Katie A McLaughlin; Maria Petukhova; Nancy A Sampson; Alan M Zaslavsky; Kathleen Ries Merikangas
Journal:  Arch Gen Psychiatry       Date:  2012-04

3.  Morning cortisol as a risk factor for subsequent major depressive disorder in adult women.

Authors:  T O Harris; S Borsanyi; S Messari; K Stanford; S E Cleary; H M Shiers; G W Brown; J Herbert
Journal:  Br J Psychiatry       Date:  2000-12       Impact factor: 9.319

4.  Twenty-four hour pattern of the episodic secretion of cortisol in normal subjects.

Authors:  E D Weitzman; D Fukushima; C Nogeire; H Roffwarg; T F Gallagher; L Hellman
Journal:  J Clin Endocrinol Metab       Date:  1971-07       Impact factor: 5.958

5.  Impact of gender, menstrual cycle phase, and oral contraceptives on the activity of the hypothalamus-pituitary-adrenal axis.

Authors:  C Kirschbaum; B M Kudielka; J Gaab; N C Schommer; D H Hellhammer
Journal:  Psychosom Med       Date:  1999 Mar-Apr       Impact factor: 4.312

6.  Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication.

Authors:  Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Kathleen R Merikangas; Ellen E Walters
Journal:  Arch Gen Psychiatry       Date:  2005-06

7.  Salivary cortisol levels in persons with and without different anxiety disorders.

Authors:  Sophie A Vreeburg; Frans G Zitman; Johannes van Pelt; Roel H Derijk; Jolanda C M Verhagen; Richard van Dyck; Witte J G Hoogendijk; Johannes H Smit; Brenda W J H Penninx
Journal:  Psychosom Med       Date:  2010-02-26       Impact factor: 4.312

8.  Children with prepubertal-onset major depressive disorder and anxiety grown up.

Authors:  M M Weissman; S Wolk; P Wickramaratne; R B Goldstein; P Adams; S Greenwald; N D Ryan; R E Dahl; D Steinberg
Journal:  Arch Gen Psychiatry       Date:  1999-09

Review 9.  Cortisol and depression: three questions for psychiatry.

Authors:  J Herbert
Journal:  Psychol Med       Date:  2012-05-08       Impact factor: 7.723

10.  The economic consequences of social phobia.

Authors:  Anita Patel; Martin Knapp; Juliet Henderson; David Baldwin
Journal:  J Affect Disord       Date:  2002-04       Impact factor: 4.839

View more
  24 in total

1.  Colon-delivered short-chain fatty acids attenuate the cortisol response to psychosocial stress in healthy men: a randomized, placebo-controlled trial.

Authors:  Bram Vervliet; Kristin Verbeke; Lukas Van Oudenhove; Boushra Dalile; Gabriela Bergonzelli
Journal:  Neuropsychopharmacology       Date:  2020-06-10       Impact factor: 7.853

Review 2.  Annual Research Review: Early adversity, the hypothalamic-pituitary-adrenocortical axis, and child psychopathology.

Authors:  Kalsea J Koss; Megan R Gunnar
Journal:  J Child Psychol Psychiatry       Date:  2017-07-17       Impact factor: 8.982

3.  Positive and negative affect and arousal: cross-sectional and longitudinal associations with adolescent cortisol diurnal rhythms.

Authors:  Lindsay T Hoyt; Michelle G Craske; Susan Mineka; Emma K Adam
Journal:  Psychosom Med       Date:  2015-05       Impact factor: 4.312

4.  Circulating angiogenic cell function is inhibited by cortisol in vitro and associated with psychological stress and cortisol in vivo.

Authors:  Kirstin Aschbacher; Ronak Derakhshandeh; Abdiel J Flores; Shilpa Narayan; Wendy Berry Mendes; Matthew L Springer
Journal:  Psychoneuroendocrinology       Date:  2016-02-23       Impact factor: 4.905

5.  An experimental test of the fetal programming hypothesis: Can we reduce child ontogenetic vulnerability to psychopathology by decreasing maternal depression?

Authors:  Elysia Poggi Davis; Benjamin L Hankin; Danielle A Swales; M Camille Hoffman
Journal:  Dev Psychopathol       Date:  2018-08

Review 6.  Biological markers for anxiety disorders, OCD and PTSD: A consensus statement. Part II: Neurochemistry, neurophysiology and neurocognition.

Authors:  Borwin Bandelow; David Baldwin; Marianna Abelli; Blanca Bolea-Alamanac; Michel Bourin; Samuel R Chamberlain; Eduardo Cinosi; Simon Davies; Katharina Domschke; Naomi Fineberg; Edna Grünblatt; Marek Jarema; Yong-Ku Kim; Eduard Maron; Vasileios Masdrakis; Olya Mikova; David Nutt; Stefano Pallanti; Stefano Pini; Andreas Ströhle; Florence Thibaut; Matilde M Vaghi; Eunsoo Won; Dirk Wedekind; Adam Wichniak; Jade Woolley; Peter Zwanzger; Peter Riederer
Journal:  World J Biol Psychiatry       Date:  2016-07-15       Impact factor: 4.132

7.  Emotion Regulation Regulates More than Emotion: Associations of Momentary Emotion Regulation with Diurnal Cortisol in Current and Past Depression and Anxiety.

Authors:  Kirsten Gilbert; Susan Mineka; Richard E Zinbarg; Michelle G Craske; Emma K Adam
Journal:  Clin Psychol Sci       Date:  2016-10-12

8.  The cortisol awakening response (CAR) interacts with acute interpersonal stress to prospectively predict depressive symptoms among early adolescent girls.

Authors:  Catherine B Stroud; Suzanne Vrshek-Shallhorn; Emily M Norkett; Leah D Doane
Journal:  Psychoneuroendocrinology       Date:  2019-04-27       Impact factor: 4.905

9.  Etiologic specificity of waking Cortisol: Links with maternal history of depression and anxiety in adolescent girls.

Authors:  Brandon L Goldstein; Greg Perlman; Roman Kotov; Joan E Broderick; Keke Liu; Camilo Ruggero; Daniel N Klein
Journal:  J Affect Disord       Date:  2016-10-11       Impact factor: 4.839

10.  Endogenous in-session cortisol during exposure therapy predicts symptom improvement: Preliminary results from a scopolamine-augmentation trial.

Authors:  Kate R Kuhlman; Michael Treanor; Gabriella Imbriano; Michelle G Craske
Journal:  Psychoneuroendocrinology       Date:  2020-03-20       Impact factor: 4.905

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.